Boston Scientific Corp (BSX) stock
BSXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 2, 2026Score 14/3050% below fair value
$44.20−0.93 (-2.06%)
Close on Nov 12, 2026Market cap $64.06BP/E 18.7Yield –
Boston Scientific enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Boston Scientific's enterprise value was $79.59B on Nov 11, 2026, against $162.23B a year earlier. Over the last 5 years it ranged from $62.49B to $170.72B, with a median of $89.51B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $79.59B | -48.0% |
| 2025 | Dec 31, 2025 | $152.92B | +8.4% |
| 2024 | Dec 31, 2024 | $141.05B | +52.8% |
| 2023 | Dec 29, 2023 | $92.30B | +23.4% |
| 2022 | Dec 30, 2022 | $74.79B | +10.1% |
| 2021 | Dec 31, 2021 | $67.96B | +16.6% |
| 2020 | Dec 31, 2020 | $58.26B | -20.9% |
| 2019 | Dec 31, 2019 | $73.64B | +33.0% |
| 2018 | Dec 31, 2018 | $55.36B | +40.1% |
| 2017 | Dec 29, 2017 | $39.50B | +14.0% |
| 2016 | Dec 30, 2016 | $34.64B | +14.3% |
| 2015 | Dec 31, 2015 | $30.31B | +40.5% |
| 2014 | Dec 31, 2014 | $21.58B | +9.1% |
| 2013 | Dec 31, 2013 | $19.77B | +68.0% |
| 2012 | Dec 31, 2012 | $11.77B | -1.9% |
| 2011 | Dec 30, 2011 | $12.00B | -28.9% |
| 2010 | Dec 31, 2010 | $16.88B | -7.1% |
| 2009 | Dec 31, 2009 | $18.17B | – |
See a number that looks wrong?